Mayo ClinicMayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2023 (CME)

Navigating Current and Emerging Trends in Hepato-Pancreatico-Biliary Cancers

In the complex landscape of hepato-pancreatico-biliary cancers, this symposium aims to provide a clear understanding of the latest diagnostic and therapeutic strategies, and their implications for clinical practice.

CME Activity Overview:

• Course Title: Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2023
• Course Dates: November 10-11, 2023
• Location: Encore at Wynn Las Vegas, Las Vegas, Nevada
• Format: Live (in-person) and Livestream (virtual) attendance options
• Available credit: 8.75 ABS, 8.75 AMA PRA Category 1 Credit™, 8.75 Attendance
• Registration Fee:
  • MD, DO, PhD: $610
  • Allied Health, NP, PA, RN, Fellows, Residents, Retired: $485
• Course Directors: Tanios S. Bekaii-Saab, MD, Mitesh J. Borad, MD, Sean P. Cleary, MD, and G. Dan Duda, DMD, PhD
• Collaboration: In association with the International Association of Surgeons, Gastroenterologists and Oncologists (IASGO)
• Target Audience: Surgeons, gastroenterologists, medical and radiation oncologists, laboratory scientists, and allied health professionals in specialties like medical oncology, hematology, gastroenterology, radiation oncology, surgical oncology, pathology, radiology, and laboratory research science.

Learning Objectives:

• Discuss novel treatment options for patients with limited oligometastatic pancreas, liver, and biliary cancers.
• Understand and apply current and emerging early diagnosis strategies for liver cancer.
• Identify patients who would benefit from liver transplantation, surgical resection, radiation therapy, or other loco-regional approaches.
• Integrate innovative molecularly-targeted strategies into clinical trial participation.
• Determine the appropriate first and second line therapy regimens for advanced pancreatic, liver, and biliary cancers.
• Outline the latest scientific advances in the treatment and understanding of pancreatic, liver, and biliary cancers.

Did You Know?
Liver cancer is the sixth most commonly diagnosed cancer and the fourth leading cause of cancer death worldwide.